To confirm the role of circRNAs in TCF3::PBX1 ALL, circBARD1 was selected for loss-of-function studies using the CRISPR/Cas13d technique, which demonstrated higher efficiency and lower off-target rates on linear mRNAs compared to shRNA-mediated circRNA silencing [33]. This evidence concerns the gene TCF3 and acute lymphoblastic leukemia.